NHS England and Wales to Offer Ponvory at Low or No Cost for RRMS
Note: This story was updated Jan. 12, 2022, to note that Ponvory is approved in the U.K. for people with relapsing forms of MS who have active disease, defined by clinical or imaging features. The National Institute for Health and Care Excellence (NICE) has recommended thatĀ Ponvory (ponesimod)…